Abstract:Abstract. Microchimerism has been suggested to play an important role in the long‐term acceptance of allogeneic organ grafts by transplant patients and for the maintenance of a state of donor‐specific low responsiveness. In order to elucidate the kinetics of the development of chimerism we have performed a follow‐up analysis in 10 pediatric patients with living‐related liver transplantation (LRLTX). Blood samples obtained during the first 6 months and at 18 months post‐transplant and skin biopsies taken at one month were analysed for the presence of donor cells by PCR using donorspecific HLA‐DRB1 primer pairs or primers for a Y chromosome‐specific sequence. Furthermore 13 long‐term patients more than 2 yr after LRLTX were studied at two different time points. In the follow‐up studies donor cells could be demonstrated in the blood of all patients immediately after transplantation. After a gradual decline all patients became chimerism‐negative for several weeks or months. At 6 months, however, in five of eight patients tested and at 18 months in six of nine patients donor cells had reappeared. This biphasic pattern in the development of chimerism is proposed to reflect the occurrence of different donor‐derived cell populations in the recipient. The population giving rise to the first wave of chimerism probably represents matured cells with a limited lifespan which are released from the graft into the circulation of the recipient during the first weeks after transplantation. The population of cells occurring with the second wave of chimerism is likely to have been generated by donor‐derived cells with stem cell potential located either in the graft or in the hematopoetic organs of the recipient after emigration from the graft. This model may be able to explain fluctuations in the incidence and degree of microchimerism described in other patient populations during the first year post‐transplant. Of the 13 long‐term patients, chimerism could be demonstrated in 11. In seven patients it was detected in both blood and skin, in three patients the results obtained for blood and skin were discordant. In one patient only blood was analysed. It is not clear whether the negative results really reflected the absence of chimerism or whether the number of donor cells was below the level of detectability.

Endothelial chimerism in renal allograft

Endothelial Cell Chimerism by Fluorescence in Situ Hybridization in Gender Mismatched Renal Allograft Biopsies

Prognosis of Endothelial Chimerism in Renal Allograft

Application of fluorescence in situ hybridization in analyzing endothelial chimerism in renal allograft

Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology

Prediction of Subclinical Renal Allograft Rejection by Vascular Endothelial Growth Factor in Serum and Urine.

Histological Isolated Endarteritis Benefits Glomerular Filtration Rate And Allograft Survival After Anti-Rejection Treatment

Effects of chimerism on the mice heart transplanted survival with the bone marrow infusion.

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

[Analysis of Microchimerism in Living Renal Transplantation Between Mothers and Children Relationship].

Correlation Of Chimerism With Acute Graft-Versus-Host Disease In Rats Following Liver Transplantation

High Serum Level of the Soluble CD30 Identifies Chinese Kidney Transplant Recipients at High Risk of Unfavorable Outcome

Pre-transplant Serum Concentrations of Anti-Endothelial Cell Antibody in Panel Reactive Antibody Negative Renal Recipients and Its Impact on Acute Rejection

Short Tandem Repeat Analysis in a Living Related Donor Adult Renal Transplant Recipient with Rare Natural Chimerism.

Using FISH and PCR Techniques to Detect Microchimerism in Liver and Renal Transplant Recipients

Association of Fc Gamma Receptor IIIB Polymorphism with Renal-Allogrft in Chinese

Study on Organ Transplantation Chimerism by Polymerase Chain Reaction Technique

Acute rejection episodic outcomes resulted from pre-transplant serum level of the soluble CD30 in kidney transplant recipients

Development of microchimerism in pediatric patients after living‐related liver transplantation

Association of Pre-Transplant Serum Level of Anti-Endothelial Cell Antibody with Acute Rejection in Kidney Transplant Recipients

Outcomes of Allograft from Donor Kidney Microthrombi and Secondary Recipient Thrombotic Microangiopathy: Should We Consider Loosening the Belt?